SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 53.10 |
| Enterprise Value ($M) | 7.89 |
| Book Value ($M) | 57.72 |
| Book Value / Share | 1.86 |
| Price / Book | 0.92 |
| NCAV ($M) | 44.42 |
| NCAV / Share | 1.43 |
| Price / NCAV | 1.20 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.94 |
| Return on Assets (ROA) | -0.57 |
| Return on Equity (ROE) | -0.64 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 7.99 |
| Current Ratio | 7.99 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 55.26 |
| Assets | 68.56 |
| Liabilities | 10.84 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Zeskind Benjamin J. | |||
| 13G/A | Cormorant Asset Management, LP | 0.00 | -100.00 | |
| 13G/A | Citadel Advisors Llc | 0.00 | ||
| 13G/A | Price T Rowe Associates Inc /md/ | 3.10 | -73.05 | |
| 13G/A | BlackRock, Inc. | 4.70 | -34.34 | |
| 13G/A | Merrin Investors LLC | 9.46 | 15.17 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 183,857 | 431,250 | 42.63 | |
| 37,752 | 195,924 | 19.27 | |
| 65,502 | 255,021 | 25.68 | |
| 29,153 | 163,343 | 17.85 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| HRMY – Harmony Biosciences Holdings, Inc. | HROW – Harrow, Inc. |
| IKNA – Ikena Oncology, Inc. | IOVA – Iovance Biotherapeutics, Inc. |
| IRON – Disc Medicine, Inc. |
Financial data and stock pages provided by
Fintel.io